![Nicole White](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicole White
Corporate Officer/Principal presso ASSEMBLY BIOSCIENCES, INC.
Patrimonio netto: 194 723 $ in data 31/05/2024
Profilo
Nicole S.
White is currently the Chief Manufacturing Officer at Assembly Biosciences, Inc. She started this position in 2022.
Prior to her current role, she worked at Gossamer Bio, Inc. as the Senior Director & Head-Process Chemistry from 2019 to 2020.
Before that, she was the Director-CMC at Abide Therapeutics, Inc. from 2017 to 2018.
Nicole's earliest position was as a Principal at Gilead Sciences, Inc. from 2009 to 2015.
She holds a doctorate degree from the University of California, Irvine and an undergraduate degree from the University of California San Diego.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
23/05/2024 | 12 853 ( 0.23% ) | 194 723 $ | 31/05/2024 |
Posizioni attive di Nicole White
Società | Posizione | Inizio |
---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | 17/11/2020 |
Precedenti posizioni note di Nicole White
Società | Posizione | Fine |
---|---|---|
GOSSAMER BIO, INC. | Corporate Officer/Principal | 01/11/2020 |
Abide Therapeutics, Inc.
![]() Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/04/2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2015 |
Formazione di Nicole White
University of California, Irvine | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
GOSSAMER BIO, INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Aziende private | 1 |
---|---|
Abide Therapeutics, Inc.
![]() Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Nicole White